Bendroflumethiaz and blood creatine phosphokinase increased Patient Reports February 11, 2012

Bendroflumethiaz Side Effects Report #5513739-1
Bendroflumethiaz side effect was reported by a Physician from UNITED KINGDOM on Nov 06, 2007. Female patient, 69 years of age, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Bendroflumethiaz. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myalgia, myositis . Bendroflumethiaz dosage: unknown. During the same period patient was treated with IRBESARTAN, LANSOPRAZOLE, NITRAZEPAM, LETROZOLE. Patient recovered.

Bendroflumethiaz Side Effects Report #5519025-8
Bendroflumethiaz side effect was reported by a Physician from UNITED KINGDOM on Nov 09, 2007. Female patient, 69 years of age, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Bendroflumethiaz. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myalgia, myositis . Bendroflumethiaz dosage: unknown. During the same period patient was treated with IRBESARTAN, LANSOPRAZOLE, NITRAZEPAM, LETROZOLE. Patient recovered.